Back to search results
NCT02040714

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Enrolling by Invitation
Not specifiedAges 1–18Observational
Texas Scottish Rite Hospital for Children
~1,500 participants
Updated 2025-05-06 on ClinicalTrials.gov
What's tested:Osteotomy + Long Term Non-Weight BearingOsteotomy + Short Term Non-Weight BearingNonoperative ObservationMultiple Epiphyseal Drilling

At a glance

Recruiting sites
0 of 46 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sphericity deviation score of the femoral head
Measured over 5 years post intervention

Conditions

Legg Calve Perthes Disease

Explore related trials

Femoral osteosclerosisPerthes Disease

Where it's being run

46 sites across 35 states
California4
New York3
Germany3
Minnesota2
Ohio2
Texas2
United Kingdom2
Alabama1

Study leadership

  • Harry KW Kim, MD, MS · STUDY_CHAIR · Texas Scottish Rite Hospital for Children

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosed with Legg-Calvé-Perthes disease
Between age 1-18
Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or corticosteroid therapy are also eligible.

Exclusion

Patients with previous surgical treatment on the affected hip

What this trial measures

  • Sphericity deviation score of the femoral head5 years post intervention

    The primary outcome for each age group will be a quantitative estimate of the sphericity of the femoral head as a measure of femoral head deformity. A more deformed head will be less spherical. Greater deformity leads to an increased risk of arthritis early in life.